A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers

NCT00698022 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Risperidone
DRUG: Mifepristone
DRUG: Risperidone-matched placebo
DRUG: Mifepristone-matched placebo

Sponsor

Corcept Therapeutics